MCCORMICK FRANK sold BBIO
September 5, 2025 · Form 4 insider transaction
MCCORMICK FRANK sold 74,000 shares of BridgeBio Pharma, Inc. at $53.16 per share, a transaction worth $3.93M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
74,000
Price
$53.16
Total value
$3.93M
InsiderMCCORMICK FRANK
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 5, 2025
Filing dateSeptember 8, 2025
Shares owned after83,275
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the weighted average sale price of the shares sold from $52.96 to $53.39 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.